论文信息 - EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases - 字舞流文

EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases

F. Hirsch | J. Zhao | Qinghua Xu | T. Jiang | S. Ren | Caicun Zhou | G. Gao | Xue-Fei Li | Chao Zhao | Xiaoxia Chen | A. Xiong | Q. Chu | C. Su | F. Zhou | Ya-ping Xu | Wei Li | Hui-juan Wang | Fengying Wu | F. Hirsch